Vistagen announces reverse stock split as part of Nasdaq compliance plan
Jun. 06, 2023 11:33 AM ETVistaGen Therapeutics, Inc. (VTGN)By: Deepa Sarvaiya, SA News Editor2 Comments
- Vistagen (NASDAQ:VTGN) to implement a stockholder-approved a one-for-thirty reverse stock split of its outstanding shares of common stock, effective June 7, 2023.
- The primary corporate and strategic objectives for reverse split is to re-establish compliance with Nasdaq’s minimum bid price requirement, to increase awareness of the Company, and to broaden the Company’s market base through enhanced access to institutional investors, mutual funds, family office investors, the general investing public and healthcare-focused sell-side research analysts.
- Accordingly, upon effectiveness of the reverse stock split, every thirty shares of Vistagen common stock outstanding as of the effective date will be automatically consolidated into one share of Vistagen common stock.
- VTGN is -17.8358% to $0.1101
- Source: Press Release